A Phase 1, Randomized Pharmacokinetic and Safety Study of a 90 Day Intravaginal Ring Containing Tenofovir
Phase of Trial: Phase I
Latest Information Update: 11 Oct 2019
Price : $35 *
At a glance
- Drugs Tenofovir (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 04 Oct 2019 Status changed from active, no longer recruiting to completed.
- 23 Jul 2019 Status changed from recruiting to active, no longer recruiting.
- 18 Dec 2018 Planned End Date changed from 30 Nov 2019 to 28 Feb 2020.